Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Safety and Efficacy of DCA for the Treatment of Brain Cancer

This study has been completed.
Capital Health, Canada
Information provided by (Responsible Party):
University of Alberta Identifier:
First received: October 4, 2007
Last updated: October 10, 2014
Last verified: February 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)